We are live on ! Find out more
CG

Column Group Portfolio holdings

AUM $88.1M
1-Year Est. Return 148.03%
This Fund
S&P 500
This Quarter Est. Return
-5.78%
1 Year Est. Return
+148.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+23.89%
10 Year Est. Return
AUM
$277M
AUM Growth
-$23.8M
Cap. Flow
-$135K
Cap. Flow %
-0.05%
Top 10 Hldgs %
100%
Holding
7
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
SRZN icon
Surrozen
SRZN
+$135K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$43.7B
$99.2M 35.85%
4,577,840
NGM
2
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$74M 26.76%
18,136,735
RAPT
3
DELISTED
RAPT Therapeutics
RAPT
$49.2M 17.79%
335,078
TNYA icon
4
Tenaya Therapeutics
TNYA
$163M
$26.8M 9.69%
9,400,290
ORIC icon
5
Oric Pharmaceuticals
ORIC
$1.44B
$20.3M 7.35%
3,568,181
SRZN icon
6
Surrozen
SRZN
$282M
$5.57M 2.01%
616,542
-11,111
-2% -$135K
EFTR
7
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$1.52M 0.55%
172,373

Similar funds

Column Group's Q1 2023 Portfolio in Review

As of Q1 2023, Column Group held 7 positions worth $277M, down 7.9% from $300M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 0%. Column Group opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Column Group's biggest Q1 2023 reduction was Surrozen, cutting an estimated $135K.
  • Column Group's ten largest holdings make up 100% of its $277M portfolio in Q1 2023.
  • Column Group opened 0 new positions and closed 0 in Q1 2023.
  • Column Group's portfolio value fell 7.9% quarter-over-quarter to $277M.

Based on Column Group's 13F filing for Q1 2023, filed 15 May 2023.